W R Bachman, J K Brennan. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultCombined Modality TherapyCyclosporine/therapeutic useDanazol/therapeutic useDrug ResistanceFemaleHumansImmunoglobulins, Intravenous/therapeutic useImmunosuppressive Agents/therapeutic useInterleukins/physiologyMethylprednisolone Hemisuccinate/therapeutic usePlasma ExchangePregnancyPregnancy Complications, Hematologic/drug therapyPregnancy Complications, Hematologic/immunologyPregnancy Complications, Hematologic/therapyPurpura, Thrombotic Thrombocytopenic/drug therapyPurpura, Thrombotic Thrombocytopenic/immunologyPurpura, Thrombotic Thrombocytopenic/therapySplenectomyVincristine/therapeutic use
Substances: See more » Immunoglobulins, IntravenousImmunosuppressive AgentsInterleukinsMethylprednisolone HemisuccinateVincristineCyclosporineDanazol
Year: 1996 PMID: 8571946 DOI: 10.1002/(SICI)1096-8652(199601)51:1<93::AID-AJH16>3.0.CO;2-C
Source DB: PubMed Journal: Am J Hematol ISSN: 0361-8609 Impact factor: 10.047